Wing Cheng

Wing Cheng has held various roles in the pharmaceutical and medical device industries since 2007. In 2007, they were a member of the Medical Device Expert Group (MDEG) Classification and Borderline for the European Commission. From 2009 to 2010, they were a Coordinator Early Phase and Project Manager/Medical Assessor at The Dental and Pharmaceutical Benefits Agency, TLV. From 2010 to 2013, they were the Chairman and Head of Preschool at Yrsa Förskola Ekonomisk Förening. From 2014 to 2015, they were a Manager Regulatory Group at Cepheid AB. From 2015 to 2018, they were a Manager Clinical Utility, R&D Allergy at Thermo Fisher Scientific. From 2018 to 2020, they were a Director Market Access and Quality Assurance at Biovica International AB. From 2020 to 2021, they were a Co-Founder, VP Regulatory and Market Access, and Chief Executive Officer at Strike Pharma AB. Since 2021, they have been a Director Business Science at Immuneed.

Wing Cheng obtained a Board of Directors Certification from EFL - Executive Education in 2021-2022, an Executive MBA from Chefakademin in 2017-2020, a PhD in Clinical Immunology from Uppsala University in 2001-2005, a Master of Science in Molecular Biotechnology from Uppsala University in 1993-2000, and a QA/RA Leader Medical Devices Certification from SBQ Certification AB in 2021.